FIELD: medicine.
SUBSTANCE: invention is intended for prevention of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) exacerbations. Against the background of basic therapy, interferon inducer Tiloron is prescribed according to the following scheme: 1st year - 1st day - 250 mg once, 2nd day - 125 mg once and then 2 days later 125 mg once, 1.25 per course; for the 2nd year the course is repeated in the preseason ARVI period: 1st day - 250 mg, 2nd - 125 mg and then 2 days later 125 mg once, 750 mg per course.
EFFECT: decreased severity and frequency of infectious exacerbations of bronchial asthma and chronic obstructive pulmonary disease and prolongation of remission time.
2 cl, 6 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PATIENTS' PREVENTIVE VACCINATION | 2006 |
|
RU2348402C2 |
| METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA AND/OR CYSTIC FIBROSIS ACCOMPANYING INFLUENZA IN CHILDREN | 2013 |
|
RU2522276C1 |
| METHOD FOR TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN SUFFERING FROM ACUTE RESPIRATORY VIRAL INFECTION (ARVI) OFTEN AND/OR FOR A LONG TIME | 2001 |
|
RU2271828C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA | 2008 |
|
RU2391663C1 |
| METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600833C1 |
| TEST SYSTEM FOR DETERMINATION OF INTERFERON, IL23 INTERLEUKINE AND MXA ANTI-VIRUS PROTEIN RNA | 2016 |
|
RU2627179C1 |
| METHOD OF PREVENTING INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN CHILDREN SUFFERING BRONCHIAL ASTHMA | 2011 |
|
RU2456020C1 |
| METHOD FOR PREDICTING EXACERBATIONS OF BRONCHIAL ASTHMA FOR THE NEAR FIRST YEAR IN PATIENTS WITH CONCOMINANT OBESITY | 2018 |
|
RU2655829C1 |
| METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
| METHOD FOR PREDICTION OF INFECTIOUS COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2595853C1 |
